Atypical Antipsychotics
Changes of Body Weight and Triglyceride Level in Schizophrenia Patients Treated with Atypical Antipsychotics
... Abstract Schizophrenia is a syndrome that could cause a serious functional decline and an extensive health problems. Cardiovascular morbidity and mortality among Schizophrenis patients has been linked to high prevalence ...
7
Costs in the treatment of schizophrenia in adults receiving atypical antipsychotics : an eleven-year cohort in Brazil
... increasingly atypical antipsy- chotics, coupled with psychological and psychosocial interventions [3, ...first-generation antipsychotics, such as chlor- promazine and haloperidol, and atypical ...
13
Adverse Drug Reactions Affiliated with Atypical Antipsychotics in Patients with Schizophrenia
... Although atypical antipsychotics are known to produce fewer side effects long term treat- ment causes their own range of adverse effects such as increased risk of diabetes and hyperlipidemia, weight gain, ...
5
Are specific initiatives required to enhance prescribing of generic atypical antipsychotics in Scotland?: International implications
... the atypical antipsychotics in Scotland as they are the most prescribed ones (Figures 1 and 3), and we have already seen a considerable reduction in expenditure/ DDD for generic ...for atypical ...
15
<p>Atypical antipsychotics for Parkinson’s disease psychosis: a systematic review and meta-analysis</p>
... databases: PubMed, the Cochrane Library, ISI Web of Science, and Embase using the following combination of terms in the [Title/Abstract]: atypical antipsychotics, pima- vanserin, olanzapine, quetiapine, ...
13
Atypical antipsychotics in bipolar disorder: systematic review of randomised trials
... general, atypical antipsychotics are effective in treating both phases of bipolar disorder compared with placebo, and as effective as established drug therapies, though only two (olanzapine and quetiapine) ...
17
Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
... the atypical antipsychotics [10,14] tend to report lower prevalence rates of antipsychotic polyphar- macy, whereas studies using more recent data reported higher polypharmacy rates ...
11
Are specific initiatives required to enhance prescribing of generic atypical antipsychotics in Scotland? International implications
... with atypical antipsychotics ...prescribed atypical antipsychotic drugs [44,45]. In the past, atypical antipsychotic drugs have been perceived as generally having a favourable cardiac safety ...
15
Adherence and persistence to typical and atypical antipsychotics in the naturalistic treatment of patients with schizophrenia
... 4 atypical agents and a descending order in adherence levels: clozapine, olanzapine, risperidone, and quetiapine, with similar and intermediate levels of adherence for risperidone- and quetiapine-treated ...
12
Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis
... Competing interests: JG, as director of the Centre for Evidence Based Mental Health, has run workshops around the United Kingdom, organised independently, but often sponsored by pharmaceutical companies. The centre has ...
7
DOCKING AND PHYSICOCHEMICAL SIMILARITY STUDIES ON INDOLE BASED ATYPICAL ANTIPSYCHOTICS
... binding of the indole based atypical antipsychotics 1- 6. The docking study effectively reproduced the receptor binding profiles of the established drugs. Inspite of possessing a novel structure seemingly ...
11
Comparison of Adverse Effects of Newer Atypical Antipsychotics: An Evidence Based Review
... Aim: To Compare the safety of asenapine and iloperidone as per informa- tion available in public domain. Method: In addition to their USFDA ap- proved prescribing information, literature on these two drugs from Pubmed ...
5
<p>Atypical antipsychotics-induced metabolic syndrome and nonalcoholic fatty liver disease: a critical review</p>
... The atypical antipsychotics (AAPs) have been used as fi rst-line drugs in psychia- tric practice for a wide range of psychotic disorders, including schizophrenia and bipolar ...
13
The efficacy, acceptability, and safety of five atypical antipsychotics in patients with first-episode drug-naïve schizophrenia: a randomized comparative trial
... first-generation antipsychotics (FGAs) were still used in some countries, they were no longer widely used in recent years due to high rates of extrapy- ramidal side effects ...first-generation ...
9
ATYPICAL ANTIPSYCHOTICS FROM SCRATCH TO THE PRESENT
... conventional antipsychotics and non-compliance among patients limits long term treatment with conventional ...class, atypical antipsychotics owning low propensity to cause EPS, efficacy against ...
21
Early predictors of poor treatment response in patients with schizophrenia treated with atypical antipsychotics
... to antipsychotics, coupled with relevant patients’ characteristics, to forecast the subsequent response in the treatment of patients with ...after atypical antipsychotics treatment in schizophrenic ...
8
Use of atypical antipsychotics in the elderly: a clinical review
... of atypical antipsychotic drugs in the elderly has become wider and wider in recent years; in fact, these agents have novel receptor binding profiles, good efficacy with regard to negative symptoms, and reduced ...
11
<p>Impact of Atypical Antipsychotics as Adjunctive Therapy on Psychiatric Cost and Utilization in Patients with Major Depressive Disorder</p>
... In the absence of comparative trials, evidence from real-world retrospective studies can support clinical deci- sion-making. While a few real-world studies compare different adjunctive AAPs in MDD, these studies have not ...
9
Atypical antipsychotics in the treatment of early-onset schizophrenia
... Abstract: Atypical antipsychotics (AAPs) have been successfully used in early-onset schizophrenia (EOS). This review summarizes the randomized, double-blind, controlled stud- ies of AAPs in EOS, including ...
7
Atypical antipsychotics induce human osteoblasts apoptosis via Wnt/β-catenin signaling
... of atypical antipsychotics, it is not to deny APs but to use it rationally in clinical such as schizophrenia patients with high osteoporotic risk need special attention with APs ...
10